Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Recruiting NCT05654493

Use of Micropulse Trans-Scleral Cyclophotocoagulation Laser (MP-TSCPC) for Glaucoma Patients

Conditions: Glaucoma

Sex: All

Ages: 18 Years – N/A

Enrollment: 50

Sponsor: Mayo Clinic

Location: United States

Summary

The purpose of this study is to evaluate the clinical outcomes of the Micropulse Trans-Scleral Cyclophotocoagulation Laser (MP-TSCPC) after 1 day, 1 week,1 month, 3 months, 6 months and one year of follow-up, with the intent to evaluate the efficacy of using MP-TSCPC to treat glaucoma patients.

Eligibility Criteria

Inclusion Criteria:Diagnose of glaucomaIndication to be submitted to the procedureExclusion Criteria:Significant thinning of the scleraCurrent eye infection or inflammationIntraocular surgery performed less than 2 months prior to the enrollment in the study

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05654493). StuddyBuddy aggregates publicly available trial information.